Modus Advisors, LLC Sorrento Therapeutics, Inc. Transaction History

Modus Advisors, LLC

  • $295 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 05, 2021
BUY
$7.03 - $16.51 $34,067 - $80,007
4,846 Added 32.61%
19,706 $163,000
Q4 2020

Jan 08, 2021
BUY
$5.76 - $11.95 $85,593 - $177,577
14,860 New
14,860 $101,000
Q3 2020

Oct 01, 2020
SELL
$6.17 - $18.82 $61,700 - $188,200
-10,000 Closed
0 $0
Q2 2020

Jul 01, 2020
BUY
$1.73 - $6.76 $17,300 - $67,600
10,000 New
10,000 $63,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Modus Advisors, LLC Portfolio

Follow Modus Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Modus Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Modus Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email